Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456216
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2024-06-05
Brief Title:
Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population
Sponsor:
Max Healthcare Insititute Limited
Organization:
Max Healthcare Insititute Limited
Study Overview
Official Title:
Performance Evaluation of Diagnostic Accuracy Sensitivity and Specificity of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population Sick Population and in Cancer Free Healthy Population
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Performance evaluation of diagnostic accuracy Sensitivity and Specificity of PanTum detect Test for detection of solid tumours in known cancer population Sick population and in cancer free Healthy population
Detailed Description:
PanTum Detect is a simple blood test that can detect presence of solid tumors using two important tumor biomarkers - Apo 10 and TKTL-1 Most tumors develop slowly and gradually From the first tumor cell to the identification of the tumor itself there can be a timespan of many years The turning point where a locally growing tumor develops into an invasive metastasizing cancer is paramount for curability It is the objective of PanTum Detect to detect a tumor in time before this critical turning point Such locally growing tumors can often easily be removed by surgery or treated successfully
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None